The global sinus dilation devices market size is estimated to reach USD 5.69 billion by 2030, registering a CAGR of 9.6%, according to a new report by Grand View Research, Inc. Changes in lifestyle, increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The introduction of technologically advanced devices is also one of the key factors boosting market growth. Major market players are focusing on R&D activities to introduce minimally invasive procedures creating a positive impact on the adoption of MIS procedures.

Some of the inventions in the market related to endoscopic approaches include a nasal endoscope, rhinoscopes, and balloon sinus dilation devices. An increase in medical reimbursements across major markets is likely to fuel the market growth. Rising adoption of health insurance and growing per capita expenditure coupled in developed as well as developing countries is predicted to augment the market growth.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

In November 2017, Entellus Medical, Inc. announced that Anthem, Inc., an American health insurance company, provided insurance coverage for Balloon Sinus Dilation (BSD) used in the treatment of recurrent acute sinusitis and chronic sinusitis. Anthem, Inc. is a member of the Blue Cross Blue Shield Association, the second-largest health benefits plan provider that covers around 40 million people in the U.S. Other major health insurance companies providing coverage for standalone BSD are Medicare, Aetna, Cigna, TRICARE, Humana, Health Net, Kaiser, and United Healthcare.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global nasal packing devices market sizewas valued at USD 205.2 million in 2024 and is projected to grow at a CAGR of 5.1% from 2025 to 2030.

• The global ligation devices market sizewas estimated at USD 1.2 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2030. 

Sinus Dilation Devices Market Segmentation

Grand View Research has segmented the global sinus dilation device market on the basis of product, Type, procedure, application, end-use, and region:

Sinus Dilation Devices Product Outlook (Revenue in USD Million, 2018 - 2030)

• Ballon Sinus Dilation Devices
• Endoscopes 
• Sinus Stents/Implants 
• Functional Endoscopic Sinus Surgery (FESS) Instruments Set
• Others

Sinus Dilation Devices Type Outlook (Revenue in USD Million, 2018 - 2030)

• Sinuscopes
• Rhinoscopes

Sinus Dilation Devices Procedure Outlook (Revenue in USD Million, 2018 - 2030)

• Standalone
• Hybrid

Sinus Dilation Devices Application Outlook (Revenue in USD Million, 2018 - 2030)

• Adult
• Pediatric

Sinus Dilation Devices End-use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals 
• Ambulatory Surgical Centers 
• ENT Clinics/In Office

Sinus Dilation Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Medtronic
• Smith+Nephew
• Stryker
• Intersect ENT, Inc
• Olympus Corporation
• SinuSys Corporation
• Johnson & Johnson Services, Inc.
• TE Connectivity
• InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.